139 related articles for article (PubMed ID: 1280876)
1. Immune responses of specific pathogen free foals to EHV-1 infection.
Chong YC; Duffus WP
Vet Microbiol; 1992 Oct; 32(3-4):215-28. PubMed ID: 1280876
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
[TBL] [Abstract][Full Text] [Related]
4. Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation.
Gibson JS; O'Neill T; Thackray A; Hannant D; Field HJ
Vet Microbiol; 1992 Oct; 32(3-4):199-214. PubMed ID: 1333670
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.
Tewari D; Gibson JS; Slater JD; O'Neill T; Hannant D; Allen GP; Field HJ
Arch Virol; 1993; 132(1-2):101-20. PubMed ID: 8394686
[TBL] [Abstract][Full Text] [Related]
6. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
[TBL] [Abstract][Full Text] [Related]
7. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
8. The raising of equine colostrum-deprived foals; maintenance and assessment of specific pathogen (EHV-1/4) free status.
Chong YC; Duffus WP; Field HJ; Gray DA; Awan AR; O'Brien MA; Lunn DP
Equine Vet J; 1991 Mar; 23(2):111-5. PubMed ID: 1646103
[TBL] [Abstract][Full Text] [Related]
9. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
Stokes A; Corteyn AH; Murray PK
Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells in normal horses and specific-pathogen-free foals infected with equine herpesvirus.
Chong YC; Duffus WP; Hannant D
Vet Immunol Immunopathol; 1992 Jun; 33(1-2):103-13. PubMed ID: 1321530
[TBL] [Abstract][Full Text] [Related]
11. Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine.
Yasunaga S; Maeda K; Matsumura T; Kondo T; Kai K
J Vet Med Sci; 2000 Jul; 62(7):687-91. PubMed ID: 10945284
[TBL] [Abstract][Full Text] [Related]
12. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
Crabb BS; Allen GP; Studdert MJ
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
Patel JR; Didlick S; Bateman H
Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA.
Studdert MJ; Hartley CA; Dynon K; Sandy JR; Slocombe RF; Charles JA; Milne ME; Clarke AF; El-Hage C
Vet Rec; 2003 Oct; 153(14):417-23. PubMed ID: 14582730
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
17. One way protection between equid herpesvirus 1 and 4 in vivo.
Edington N; Bridges CG
Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the proteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3: antibody response of the natural hosts.
Crabb BS; Studdert MJ
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2033-41. PubMed ID: 2170572
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a monoclonal antibody blocking ELISA for the detection of antibodies against both equine herpesvirus type 1 (EHV1) and equine herpesvirus type 4 (EHV4).
van Maanen C; de Boer-Luijtze E; Terpstra C
Vet Microbiol; 2000 Jan; 71(1-2):37-51. PubMed ID: 10665532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
